480 related articles for article (PubMed ID: 28183610)
1. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
[TBL] [Abstract][Full Text] [Related]
2. Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization.
Abd-Elrahman AA; El Nabarawi MA; Hassan DH; Taha AA
Drug Deliv; 2016 Nov; 23(9):3387-3398. PubMed ID: 27167529
[TBL] [Abstract][Full Text] [Related]
3. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
[TBL] [Abstract][Full Text] [Related]
4. Optimization of tetracycline hydrochloride adsorption on amino modified SBA-15 using response surface methodology.
Hashemikia S; Hemmatinejad N; Ahmadi E; Montazer M
J Colloid Interface Sci; 2015 Apr; 443():105-14. PubMed ID: 25540827
[TBL] [Abstract][Full Text] [Related]
5. Exploitation of 3D face-centered cubic mesoporous silica as a carrier for a poorly water soluble drug: influence of pore size on release rate.
Zhu W; Wan L; Zhang C; Gao Y; Zheng X; Jiang T; Wang S
Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():78-85. PubMed ID: 24268236
[TBL] [Abstract][Full Text] [Related]
6. Ordered mesoporous silica modified with lanthanum for ibuprofen loading and release behaviour.
Goscianska J; Olejnik A; Nowak I; Marciniak M; Pietrzak R
Eur J Pharm Biopharm; 2015 Aug; 94():550-8. PubMed ID: 26170160
[TBL] [Abstract][Full Text] [Related]
7. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
8. Luminescence functionalization of SBA-15 by YVO4:Eu3+ as a novel drug delivery system.
Yang P; Huang S; Kong D; Lin J; Fu H
Inorg Chem; 2007 Apr; 46(8):3203-11. PubMed ID: 17371013
[TBL] [Abstract][Full Text] [Related]
9. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
[TBL] [Abstract][Full Text] [Related]
10. Modification of mesoporous silica with molecular imprinting technology: A facile strategy for achieving rapid and specific adsorption.
Xu Z; Deng P; Li J; Tang S; Cui Y
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():684-693. PubMed ID: 30423755
[TBL] [Abstract][Full Text] [Related]
11. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers.
Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP
Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured SBA-15 host applied in ketorolac tromethamine release system.
Cussa J; Juárez JM; Gómez Costa MB; Anunziata OA
J Mater Sci Mater Med; 2017 Aug; 28(8):113. PubMed ID: 28625001
[TBL] [Abstract][Full Text] [Related]
14. A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems.
Trendafilova I; Szegedi Á; Yoncheva K; Shestakova P; Mihály J; Ristić A; Konstantinov S; Popova M
Eur J Pharm Sci; 2016 Jan; 81():75-81. PubMed ID: 26453768
[TBL] [Abstract][Full Text] [Related]
15. Verapamil delivery systems on the basis of mesoporous ZSM-5/KIT-6 and ZSM-5/SBA-15 polymer nanocomposites as a potential tool to overcome MDR in cancer cells.
Popova M; Mihaylova R; Momekov G; Momekova D; Lazarova H; Trendafilova I; Mitova V; Koseva N; Mihályi J; Shestakova P; St Petkov P; Aleksandrov HA; Vayssilov GN; Konstantinov S; Szegedi Á
Eur J Pharm Biopharm; 2019 Sep; 142():460-472. PubMed ID: 31336182
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterization and application of p-tert-butyl-calix[4]arene-SBA-15 mesoporous silica molecular sieves.
Huang H; Zhao C; Ji Y; Nie R; Zhou P; Zhang H
J Hazard Mater; 2010 Jun; 178(1-3):680-5. PubMed ID: 20185235
[TBL] [Abstract][Full Text] [Related]
17. Hollow mesoporous silica as a high drug loading carrier for regulation insoluble drug release.
Geng H; Zhao Y; Liu J; Cui Y; Wang Y; Zhao Q; Wang S
Int J Pharm; 2016 Aug; 510(1):184-94. PubMed ID: 27262268
[TBL] [Abstract][Full Text] [Related]
18. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
19. Modified SBA-15 mesoporous silica for heavy metal ions remediation.
Mureseanu M; Reiss A; Stefanescu I; David E; Parvulescu V; Renard G; Hulea V
Chemosphere; 2008 Nov; 73(9):1499-504. PubMed ID: 18760443
[TBL] [Abstract][Full Text] [Related]
20. Dissolution enhancement of a model poorly water-soluble drug, atorvastatin, with ordered mesoporous silica: comparison of MSF with SBA-15 as drug carriers.
Maleki A; Hamidi M
Expert Opin Drug Deliv; 2016; 13(2):171-81. PubMed ID: 26636904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
